Peptide cocktail vaccine (Iwate Medical University)

N/A

Report date: 2023/02/17 21:17:27

Base Information

Drug NamePeptide cocktail vaccine (Iwate Medical University)
Drug Alias Namepeptide cocktail vaccine (subcutaneous/HLA-A2401 and HLA-A2402 constricted, cancer)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical NeoplasmsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIwate Medical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIwate Medical University
Active IndicationsN/A
Inactive IndicationsUterine Cervical NeoplasmsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A